TerraLex Webinar: Current Legal Trends Impacting the Life Sciences Industry
Wiggin and Dana Partner, Jim Farrington, will be moderating a Terralex webinar on Wednesday, March 28, 2018 from 10:00AM to 11:00AM EDT. Wiggin and Dana attorneys, Michelle DeBarge, Toby Bannon and Monica Kolinsky will also be joining the webinar to speak on specific issues.
This webinar is an opportunity for participants to share perspectives from their jurisdiction on selected issues facing global life sciences companies.
Topics of discussion include:
- Data privacy, including how to comply with EMA and other regulatory agency requirements to disclose personal data in results from clinical trials in view of the potential conflict with the new reinforced data privacy EU regulations.
- Digital documents and digital signatures: What is the current status in law, cases, and practice?
- Commercial compliance for pharma companies: Local laws, regulations, and codes differ in certain situations (e.g, DTC advertising, pre-approval marketing). How do you choose applicable standards when advising a life sciences company operating in many jurisdictions that wants to apply a global product messaging and marketing strategy?
- Post-trial obligations to supply study drug to study participants: This sort of "obligation" varies across a spectrum from required by law, to pressure by a region of Institutions/PIs, to a suggestion from individual Institutions/PIs.
To register for this webinar, please click here.